 |
인쇄하기
취소
|
Dong-A sees 200 billion in Q2 sales
Dong-A Pharm’s sales are expected to surge up to 200 billion won in the second quarter of this year for the first time, according to market analysts.
The second-quarter sales figure reflects a sharp increase from 174.3 billion in the same period a year earlier.
They said Dong-A revenues stems from good performance of its flagship products, such as Stillen and Zydena.
In the second quar...
The second-quarter sales figure reflects a sharp increase from 174.3 billion in the same period a year earlier.
They said Dong-A revenues stems from good performance of its flagship products, such as Stillen and Zydena.
In the second quar...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.